INDP
Indaptus Therapeutics Inc
2.40$
+12.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | -0.3% | +129.7% | – | – | – | – | – | – | – | – | – | – | |
| – | – | -145.7% | – | – | – | – | – | – | – | – | – | – | |
| – | -8.6% | -21.8% | +7.7% | -14.5% | +69.2% | +13.3% | -22.9% | -30.0% | +87.5% | -82.7% | -26.1% | – | |
| – | +6.1% | +9.7% | +1.8% | -30.0% | +0.9% | +4.1% | +30.0% | -50.6% | +369.6% | -68.6% | -13.3% | – | |
| – | -1.6% | -5.7% | +4.2% | -23.5% | +32.8% | +9.6% | -2.5% | -40.6% | +207.9% | -73.5% | -16.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -10,573.4% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.